Admission Date: [**2194-6-23**]        Discharge Date: [**2194-7-3**]  Date of Birth:  [**2142-9-23**]        Sex:  F  Service:  CSU   HISTORY OF PRESENT ILLNESS:  This is a 51-year-old white female patient who is status post coronary artery bypass grafting x3 at [**Hospital3 **] Medical Center in [**2193-3-12**].
Her surgery was complicated by a sternal wound infection requiring multiple courses of antibiotics and three surgical sternal debridements.
Patient did present for cardiac surgery evaluation as well due to sternal involvement.
PAST MEDICAL HISTORY:  Coronary artery bypass graft as previously stated.
Insulin dependent-diabetes mellitus.
Humulin NPH insulin.
Glipizide 5 mg p.o.
Asacol 400 mg three tablets t.i.d.
Celexa 20 mg p.o.
Synthroid 88 mcg p.o.
Aspirin 81 mg p.o.
Advil 600-800 mg t.i.d.
Lipitor 20 mg p.o.
Temazepam 15 mg prn.
Seroquel 50 mg q.h.s.
HOSPITAL COURSE:  The patient was taken to the operating room on [**2194-6-23**], where she underwent a sternal debridement with pectoral advancement flap with Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 70**] and Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **].
She was weaned from mechanical ventilation, extubated the day of surgery.
She was begun on her preoperative oral medications and transferred out of the Intensive Care Unit to the telemetry floor.
Her cultures from the sternal wound and tissue reviewed coag-negative Staph and the patient has been continued on IV Vancomycin for this.
Continued on her IV Vancomycin.
On postoperative day four, her TSH was checked and found to be elevated and her Synthroid was increased to 100 mcg at that time.
It was their recommendation to check peripheral smears, and folate, and B12 levels and continue to follow her TSH and these are all issues that need to be continued to be addressed as the patient was discharged from rehabilitation facility.
Her Glipizide was discontinued as was her NPH insulin, and she was placed on ultimately a sliding scale coverage of regular insulin for that reason.
Ultimately, the patient will need to be resumed on her preoperative dose of NPH insulin as well as her oral hypoglycemic [**Doctor Last Name 360**] Glipizide when she is able to tolerate p.o.
Colace 100 mg p.o.
Aspirin 325 mg p.o.
Tylenol 650 mg p.o.
Percocet 1-2 tablets p.o.
Milk of magnesia 30 mL p.o.
Mesalamine DR 1200 mg p.o.
Celexa 20 mg p.o.
Lipitor 20 mg p.o.
Temazepam 15 mg p.o.
Seroquel 50 mg p.o.
Synthroid 100 mcg p.o.
Lisinopril 20 mg p.o.
Hydrochlorothiazide 25 mg p.o.
Vancomycin 750 mg IV q.12h.
Folic acid 1 mg p.o.
Ascorbic acid 500 mg p.o.
Ferrous sulfate 325 mg p.o.
Multivitamin one capsule p.o.
Ibuprofen 400-600 mg q.8h.
DISCHARGE INSTRUCTIONS:  Patient also needs to be followed up as an outpatient for her leukopenia through her primary care physician, [**Name10 (NameIs) **] she should also be monitored for her thyroid replacement and have another TSH level checked in approximately four more weeks since her Synthroid was recently increased to 100 mcg.
DISCHARGE DIAGNOSIS:  Postoperative sternal wound infection status post sternal wound debridement and pectoral flaps.
